Saana Lepola

FinVector (Finland) — Finland

Biochemistry, Genetics and Molecular Biology · Life Sciences

2h-index40citations4works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(3), Viral Infectious Diseases and Gene Expression in Insects(3), RNA Interference and Gene Delivery(2), CAR-T cell therapy research(2), Protein purification and stability(1)

Publications4 total

Industrialisation of Adenoviral Vector Production in Fixed Bed Bioreactor: A control strategy for a Monoseptic process
2025Open Access
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
Frontiers in Medicine·2023Open Access
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
Frontiers in Medicine·2022· 14 citedOpen Access
Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production
Human Gene Therapy·2020· 26 citedOpen Access

Frequent Co-authors

Hanna Leinonen(4), Eevi M. Lipponen(3), Seppo Ylä‐Herttuala(3), Hanna P. Lesch(3), Reetta A. E. Eriksson(2), Lionel Galibert(2), Sanna K. Peltola(2), Petra Tikkanen(2), Piia Käyhty(2), Igor Oruetxebarria(2), Anniina J. Valkama(2), Kari J. Airenne(2), Tommi Heikura(1), Tiina Koponen(1), Nigel Parker(1), Tiina Nieminen(1), I. Jones(1), Piia Valonen(1), Janne Weisell(1), Tiina M. Nieminen(1)